Bill Bartelson

• Company Overview: LiquidSMARTS is a private commercial development, consulting, and sales training firm specializing in clinical diagnostics, medical devices, life sciences, biotech, and healthcare industries.
• Role description: Tasked with the creation and implementation of a business development division within the organization.
• Key achievements:
• Established a new business development division within the global clinical diagnostics, life sciences, and healthcare sectors.
• Secured a key partnership with MedScout.io, a specialized data engine and mining organization.
• Identified and recruited a 38-year Mayo Clinic veteran as a contract partner for professional, accredited executive coaching services.
• Created a business development funnel exceeding $1.0M in annual revenue potential within the first 12 months, representing historical growth opportunity for the firm.

Company overview: The Binding Site provides specialist diagnostic products to clinicians and laboratory professionals worldwide by delivering innovative medical solutions that improve the diagnosis and management of blood cancers and immune disorders.

Role description: Developed and implemented strategic plans to increase awareness of global clinical diagnostic screening guidelines for monoclonal protein diseases to key clinical decision-makers, driving sustainable reagent revenue growth for TBS's flagship assay product, Freelite.

Key achievements:

• First year of Guideline Action Initiative (GAI) Program yielded four national partners generating +$239K in incremental revenues.
• Secured 29 major US healthcare systems, hospitals, and cancer centers as program participants.
• Published two AACC abstracts based on program implementations at St. Elizabeth Healthcare and TriCore Reference Laboratories.
• Achieved incremental Freelite YOY revenues of +$750K with a GAI pipeline of +$5.6M in potential revenues.

Company Overview: Abbott Laboratories' Molecular Dx Division is a global manufacturer and distributor of molecular diagnostic systems and reagents, performing clinical analysis of human DNA, RNA, and proteins at the molecular level.

Role description: Led US National Reference Laboratories, GPOs, US Government, and IDN strategic account teams comprised of 9 headcount, with a P&L responsibility for $30.6M annually.

Key achievements:

• Stabilized rapidly declining Reference Lab business unit for the first time in several years.
• Protected $20.7M in annual revenues through multiple long-term IHN contract renewals.
• Secured Beth Israel Deaconess Medical Center 7-year $5.1M contract and Northwell Health 3-year $13.6M renewal.
• Implemented national Vizient agreement, protecting legacy MedAssets & Novation members while establishing an MFN position.

Company Overview: Cardinal Health, Nuclear Pharmacy Services is a national radiopharmaceutical manufacturing service and supply distribution firm.

Role description: P&L responsibility for a $1.0B business model of radiopharmaceutical diagnostic imaging agents delivered through 129 US-based radiopharmacies.

Key achievements:

• Implemented change-management strategy resulting in +475 incremental wins totaling +$45M and 273 saves totaling +$104M in year one.
• Eliminated $7M plan deficit mid-year to achieve 100% quota and +$7M over-achievement to operating budget.
• Grew primary product line (LYMPHOSEEK) by +$6.0M to $26.0M, catalyzing a corporate acquisition from Navidea Biopharmaceuticals for the firm.
• Negotiated and secured three major GPO contract extensions with favorable terms, including HealthTrust ($174M), Premier National Radiopharm ($85M), and Premier PET ($10M).

Company Overview: GE Healthcare, Clarient Diagnostic Services is a global cancer diagnostic reference laboratory specializing in oncology testing services.

Expanded role description post corporate downsizing – Central US Region Leadership: An expanded leadership role involving management of the Central US Sales Region, involving a team of nine Account executives responsible for $50M in annual revenues.

Key achievements:

• Rebuilt the region to full capacity with five new hires within the first five months.
• Turned performance from YOY -10.5% ($4.8M) to +0.57%; +$688K; Q3 vs. Q4 2014.
• Expanded Baylor College of Medicine revenue by +15%; +$2.2M stemming from personal BD success.
• Led the nation in year-over-year collections totaling $17.2M.

Vice President, International Business Development – Americas; focused on the Western Hemisphere exclusively:

Key achievements:

• In conjunction with Baylor College of Medicine & GE Operations, successfully launched the firm's first satellite reference laboratory (Houston, TX), resulting in 30 new regional partners generating >$2.0M annually.
• Implemented exUS Laboratory Services Agreements in Israel, Ecuador, and Brazil, resulting in +900 exUS testing specimen imports for the firm.

Role description: A personal business start-up providing consultative leadership in business development within domestic and international clinical diagnostic markets.

Secured partnerships:

• Clarient Diagnostic Services – Strategy for European OEM Ab product commercialization.
• GE Healthcare – Globalization strategy development leading to VP promotion.

Company Overview: PTS Diagnostics is a manufacturer and worldwide supplier of the CardioChek clinical and consumer Point-of-Care Cholesterol Test System.

Role description: Accountability to PTS' Board of Directors and shareholders with a primary focus on investor relations, strategy development, and revenue attainment, with the long-term objective of a liquidity event, with departmental oversight and leadership of Marketing, Sales, and Customer Service.

Key achievements:

• Implemented comprehensive and upgraded People Strategy aligned with the strategic plan.
• Developed consumer research model through Nielsen Research for the CardioChek home cholesterol test, yielding product concept acceptability levels, price points, and package design.
• Restructured an unproductive distribution strategy, consolidating 85+ distributors into eight semi-exclusive contracts.
• Secured a CVS/Minute Clinic five-year national contract, including a $1.0M initial stocking order covering >500 clinics.

Company Overview: Roche Diagnostics Corporation is a worldwide leading manufacturer of in vitro medical diagnostic testing products and instrumentation.

Role description: P&L responsibility for a $155M business across clinical chemistry, immunochemistry, urinalysis, IT, and laboratory automation portfolios, incorporating 47 headcount to include management of RDC's Puerto Rican distribution arm.

Key achievements:

• Achieved the #1 national area ranking for 2001, 2002, 2004, and 2006 performance periods.
• Led nation in new COBAS analyzer launch with 137 modules (53% of total US production) and $51M capital sales (+43% YOY).
• Structured exclusive distribution contract for Puerto Rico and US Virgin Islands, resolving $465K receivables debt.
• Selected for and completed the Roche HORIZONS global leadership development program, involving a 9-month commercial project plan within the country of India.